Division of Translational Cancer Research
1 – 10 of 673
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Intrathecal pemetrexed for leptomeningeal metastases in a patient with ALK-rearranged lung adenocarcinoma : a case report
- Contribution to journal › Article
-
Mark
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genomic Characteristics Related to Histology-based Immune Features in Breast Cancer
(2025) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 38(5).
- Contribution to journal › Article
-
Mark
Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment
- Contribution to journal › Article
-
Mark
Immune Response in Triple-Negative Breast Cancer - Machine Learning-based Insights from Histology and -Omics
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer
- Contribution to journal › Article
-
Mark
Evaluation of alternative prognostic thresholds for SP142 and 22C3 immunohistochemical PD-L1 expression in triple-negative breast cancer : results from a population-based cohort
- Contribution to journal › Article
-
Mark
A two-phase epigenome-wide four-way gene–smoking interaction study of overall survival for early-stage non-small cell lung cancer
- Contribution to journal › Article
